Patients with the rs193922753 GT genotype may develop malignant hyperthermia when treated with volatile anesthetics (desflurane, enflurane, halothane, isoflurane, methoxyflurane, sevoflurane) and/or succinylcholine as compared to patients with genotype GG. Other genetic or clinical factors may also influence the risk for malignant hyperthermia.